<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7589781/table_2" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 2</label>
  <p>Principal studies evaluating the correlation between rhinovirus bronchiolitis and preschool wheezing or asthma.</p>
 </caption>
 <thead>
  <tr>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-0-.">Study, 
    <br/>Year, 
    <br/>Country 
   </th>
   <th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-1-.">Study Design, 
    <br/>Study Population 
   </th>
   <th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-2-.">Period of Study Enrollment</th>
   <th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-3-.">Age Group</th>
   <th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-4-.">Sample Size 
    <br/>Number of Cases 
   </th>
   <th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-5-.">Outcome—Measure of Interest</th>
   <th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-6-.">Results ( 
    <i>p</i>-Value) 
   </th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Koponen P et al., 
    <br/>2011, 
    <br/>Finland 
    <br/>[ 
    <a rid="B45-microorganisms-08-01620" ref-type="bibr">45</a>] 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective single-center, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis 
    <br/>with a follow-up at 5-6 years of age 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Dec 2001–May 2002 and 
    <br/>Oct 2002–May 2004 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;6 months</td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">166 infants: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 117/166 (70.5%) 
    <br/>- RV 21/166 (12.7%) 
    <br/>- Others 28/166 (16.9%) 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Current asthma, defined as a continuous maintenance medication for asthma, 
    <br/>doctor-diagnosed wheezing or prolonged 
    <br/>(4 weeks) cough apart from an infection, 
    <br/>during the preceding year and BHR in ECT 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Previous non-RSV bronchiolitis associated with more frequent current asthma in preschool-age than RSV bronchiolitis 
    <br/>(24% vs. 8.2%, 
    <br/>
    <i>p</i> = 0.01), 
    <br/>but no single virus (nor RV) was predominant in the “former non-RSV bronchiolitis” group with current asthma 
    <br/>
    <br/>At the adjusted multivariate analysis, non-RSV bronchiolitis resulted as an independent risk factor for preschool asthma 
    <br/>(aOR 3.74, 
    <br/>95% CI 1.28–10.99) 
   </td>
  </tr>
  <tr>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Midulla F et al., 
    <br/>2014, 
    <br/>Italy 
    <br/>[ 
    <a rid="B46-microorganisms-08-01620" ref-type="bibr">46</a>] 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective single-center, hospitalized children with a clinical diagnosis of bronchiolitis with yearly follow-up for 3 years since discharge</td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Oct 2004–May 2008</td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;1 year</td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">230 infants, 
    <br/>134 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 99/134 (73.9%) 
    <br/>- RV 20/134 (14.9%) 
    <br/>- Others 29/134 (21.6%) 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Recurrence of wheezing 
    <br/>(3 groups: 
    <br/>no wheezing, occasional wheezing 
    <br/>(≥2 episodes of wheezing in 3 years), recurrent wheezing 
    <br/>(≥2 episodes of wheezing in a year for3 years)) 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">RV bronchiolitis associated with recurrent wheezing than other viral groups at multivariate analysis 
    <br/>(OR 3.2, 
    <br/>95% CI 1.1-9.6, 
    <br/>
    <i>p</i> = 0.03) 
   </td>
  </tr>
  <tr>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Amat et al., 
    <br/>2018, 
    <br/>France 
    <br/>[ 
    <a rid="B47-microorganisms-08-01620" ref-type="bibr">47</a>] 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective single-center, 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis with follow-up for 3 years after discharge 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Oct 2011–May 2012</td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;1 year</td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">154 infants: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 117/154 (76%) 
    <br/>- RV 44/154 (28.6%) 
    <br/>- Others 108/154 (70.1%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 54/154 (35.1%) 
    <br/>N.B. frequency of RV + RSV infection not specified 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Diagnosis of recurrent wheezing 
    <br/>
    <br/>Sensitization (IgE rate) to aeroallergens 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant differences in the frequency of recurrent wheezing among single and mixed viral groups, 
    <br/>but initial RV-RSV co-infected bronchiolitis associated with the risk of sensitization to aeroallergens at 3 years at multivariate analysis 
    <br/>(OR 3.88, 
    <br/>95% CI 1.24–12.1, 
    <br/>
    <i>p</i> = 0.02) 
   </td>
  </tr>
  <tr>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Bergroth E et al., 
    <br/>2019, 
    <br/>Finland 
    <br/>[ 
    <a rid="B36-microorganisms-08-01620" ref-type="bibr">36</a>] 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective multicenter cohort study (MARC-30), 
    <br/>hospitalized children with a clinical diagnosis of bronchiolitis with follow-up 4 years after discharge 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nov 2008–Mar 2010</td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;2 years</td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">349 children, 
    <br/>302 virus-positive cases: 
    <br/>
    <br/>Viral types 
    <br/>- RSV 145/302 (48%) 
    <br/>- RV 101/302 (33.4%) 
    <br/>- Others 51/302 (16.9%) 
    <br/>
    <br/>Co-infections 
    <br/>- RSV + RV 8/302 (2.6%) 
    <br/>N.B. frequency of global co-infections not specified 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Use of asthma control medication 4 years after bronchiolitis</td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">RV infection associated with higher use of asthma control medication in the last year than RSV infection 
    <br/>(47% vs. 15%, aOR 3.67, 
    <br/>95% CI 1.88–7.19, 
    <br/>
    <i>p</i> &lt; 0.001) 
    <br/>
    <br/>At the multivariable analysis, RV-C was specifically associated with a higher risk for the use of asthma control medication 4 years after severe bronchiolitis 
    <br/>(aOR 3.72, 
    <br/>95% CI 1.80–7.66, 
    <br/>
    <i>p</i> &lt; 0.001) 
   </td>
  </tr>
  <tr>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Hunderi JOG et al., 
    <br/>2020, 
    <br/>Norway 
    <br/>[ 
    <a rid="B48-microorganisms-08-01620" ref-type="bibr">48</a>] 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective multicenter, 
    <br/>hospitalized children with a clinical diagnosis of moderate-severe bronchiolitis (based on a 10-pointed CSI) with follow-up 2 years after discharge 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">2010–2011</td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;2 years</td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">294 children, 
    <br/>129 virus-positive cases 
    <br/>
    <br/>Viral types 
    <br/>- RSV 107/129 (82.9%) 
    <br/>- RV 45/129 (34.9%) 
    <br/>- RV-A/B 12/45 (26.7%) 
    <br/>- RV-C 33/45 (73.3%) 
    <br/>- high RV genomic load 
    <br/>8/45 (17.8%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 170/266 (63.9%) 
    <br/>N.B. frequency of RV + RSV infection not specified 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Recurrent wheeze at 2 years (defined as ≥3 episodes, including the bronchiolitis at the enrollment)</td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Recurrent wheeze by 2 years of age was neither significantly associated with RV or RSV nor with rates of high viral load during acute infant bronchiolitis</td>
  </tr>
  <tr>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Mansbach et al., 
    <br/>2020, 
    <br/>USA 
    <br/>[ 
    <a rid="B49-microorganisms-08-01620" ref-type="bibr">49</a>] 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective multicenter cohort study (MARC-35), hospitalized children with a clinical diagnosis of bronchiolitis with follow-up 2 years after discharge with a focus on delayed viral clearance (detection of the same virus in nasal swab 3 weeks after the discharge) and sequential infection (detection of a new RSV type or RV genotype)</td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">2011–2014 
    <br/>(winter seasons) 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;1 year</td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">673 infants: 
    <br/>
    <br/>Viral typed 
    <br/>- RSV 107/673 (15.9%) 
    <br/>- RV 122/673 (18.1%) 
    <br/>
    <br/>Co-infections 
    <br/>- Coinfect. 170/266 (63.9%) 
    <br/>N.B. frequency of RV + RSV infection not directly specified 
   </td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Recurrent wheezing by age 3 years (defined as having ≥2 corticosteroid-requiring exacerbations in 6 months or ≥4 wheezing episodes in 1 year that last ≥1 day and affect sleep)</td>
   <td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant association between RSV DC, RSV SI, RV DC, RV SI, and a higher risk of recurrent wheezing 
    <br/>
    <br/>Among infants with RV at hospitalization, those with a new RV SI had a higher risk of recurrent wheezing compared to children without a new RV SI 
    <br/>(HR 2.49, 
    <br/>95% CI 1.22–5.06, 
    <br/>
    <i>p</i> = 0.01) 
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p class="fn" charset="fn">
   <p>aOR = adjusted odds ratio; BHR = bronchial hyper responsiveness; CI = confidence interval; CSI = clinical score index; DC = delayed clearance; ECT = exercise challenge test; HR = hazard ratio; IgE = immunoglobulin E; MARC = Multicenter Airway Research Collaboration; mo = month; RSV = respiratory syncytial virus; RV = rhinovirus; SI = sequential infection; y = year.</p>
  </p>
 </tfoot>
</table>
